Earnings History Data for Revolution Medicines, Inc. (RVMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Revolution Medicines, Inc.

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
26-02-2024	AH		RVMD	Revolution Medicines, Inc.	3,180	-1.14	-0.85	-0.63	Revolution Medicines GAAP EPS of -$1.14 misses by $0.28, revenue of $0.7M misses by $0.5M [2/26/2024 4:19 PM]	30.62	0.24 (0.79%)	30.27	-0.11 (-0.38%)	15.44 - 35.60	2,410,191	1,140,000	1,217
Revolution Medicines GAAP EPS of -$1.14 misses by $0.28, revenue of $0.7M misses by $0.5M [2/26/2024 4:19 PM]
06-11-2023	AH		RVMD	Revolution Medicines, Inc.	2,310	-0.99	-1.01	-0.87	Revolution Medicines GAAP EPS of $0.99 beats by $2.01, revenue of $0M misses by $0.86M [11/6/2023 4:27 PM]	21.52	-0.02 (-0.09%)	21.54	0.0 (0.00%)	15.44 - 35.60	1,683,299	3,070,000	21,235
Revolution Medicines GAAP EPS of $0.99 beats by $2.01, revenue of $0M misses by $0.86M [11/6/2023 4:27 PM]
08-08-2023	AH		RVMD	Revolution Medicines, Inc.	3,320	-0.92	-0.82	-0.82	Revolution Medicines GAAP EPS of -$0.92 misses by $0.09, revenue of $3.82M beats by $2.26M [8/8/2023 4:34 PM]	29.66	-0.51 (-1.69%)	30.17	0.0 (0.00%)	17.03 - 33.19	572,608	1,830,000	7,140
Revolution Medicines GAAP EPS of -$0.92 misses by $0.09, revenue of $3.82M beats by $2.26M [8/8/2023 4:34 PM]
08-05-2023	AH	4:05 PM ET (May 8)	RVMD	Revolution Medicines, Inc.	2,570	-0.72	-0.84	-0.78	Revolution Medicines GAAP EPS of -$0.72 beats by $0.10, revenue of $7.01M beats by $4.07M [5/8/2023 4:18 PM]	25.27	0.83 (3.40%)	24.44	0.0 (0.00%)	14.08 - 31.37	834,037	690,000	21,987
Revolution Medicines GAAP EPS of -$0.72 beats by $0.10, revenue of $7.01M beats by $4.07M [5/8/2023 4:18 PM]
27-02-2023	AH	4:05 PM ET (Feb 27)	RVMD	Revolution Medicines, Inc.	2,230	-0.63	-0.84	-0.71	Revolution Medicines GAAP EPS of -$0.63 beats by $0.18, revenue of $15.33M beats by $7.53M [2/27/2023 4:10 PM]	26.77	2.40 (9.85%)	28.00	3.63 (14.90%)	14.08 - 31.37	4,990,141	910,000	102,402
Revolution Medicines GAAP EPS of -$0.63 beats by $0.18, revenue of $15.33M beats by $7.53M [2/27/2023 4:10 PM]
07-11-2022	AH	4:00 PM ET (Nov 7)	RVMD	Revolution Medicines, Inc.	1,810	-0.87	-0.87	-0.72	Revolution Medicines GAAP EPS of -$0.87 misses by $0.02, revenue of $3.4M misses by $2.94M [11/7/2022 4:22 PM]	19.68	-0.09 (-0.46%)	19.77	0.0 (0.00%)	14.08 - 34.10	493,231	590,000	12,367
Revolution Medicines GAAP EPS of -$0.87 misses by $0.02, revenue of $3.4M misses by $2.94M [11/7/2022 4:22 PM] Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress [Nov-07-22 04:05PM]
09-08-2022	AH	4:00 PM ET (Aug 9)	RVMD	Revolution Medicines, Inc.	1,660	-0.82	-0.87	-0.60	Revolution Medicines GAAP EPS of -$0.82 beats by $0.04, revenue of $9.11M beats by $2.09M [8/9/2022 4:07 PM]	24.37	0.61 (2.57%)	23.76	0.0 (0.00%)	14.08 - 34.16	714,020	990,000	2,236
Revolution Medicines GAAP EPS of -$0.82 beats by $0.04, revenue of $9.11M beats by $2.09M [8/9/2022 4:07 PM]
09-05-2022	AH	4:05 PM ET (May 9)	RVMD	Revolution Medicines, Inc.	1,510	-0.78	-0.82	-0.53	Revolution Medicines GAAP EPS of -$0.78 beats by $0.01, revenue of $7.58M misses by $1M [5/9/2022 4:54 PM]	16.05	1.06 (7.07%)	14.99	0.0 (0.00%)	14.46 - 35.07	659,501	657,041	22,179
Revolution Medicines GAAP EPS of -$0.78 beats by $0.01, revenue of $7.58M misses by $1M [5/9/2022 4:54 PM] Further weakness as Revolution Medicines (NASDAQ:RVMD) drops 4.7% this week, taking one-year losses to 30% [May-06-22 09:50AM] Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress [May-09-22 04:02PM] Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Misses Revenue Estimates [May-09-22 05:35PM]
28-02-2022	AH	4:05 PM ET (Feb 28)	RVMD	Revolution Medicines, Inc.	1,460	-0.71	-0.65	-0.52	Revolution Medicines GAAP EPS of -$0.71 misses by $0.07, revenue of $9.46M misses by $0.49M [2/28/2022 4:37 PM]	18.56	-0.36 (-1.90%)	20.09	1.17 (6.18%)	18.07 - 50.88	478,688	460,000	256
Revolution Medicines GAAP EPS of -$0.71 misses by $0.07, revenue of $9.46M misses by $0.49M [2/28/2022 4:37 PM] Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress [Feb-28-22 04:05PM] Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Tops Revenue Estimates [Feb-28-22 06:05PM] Revolution Medicines to Participate in Cowen 42nd Annual Health Care Conference [Mar-01-22 04:05PM]
10-11-2021	AH	4:00 PM ET (Nov 10)	RVMD	Revolution Medicines, Inc.	2,480	-0.72	-0.62	-0.42	Revolution Medicines EPS misses by $0.10, misses on revenue [11/10/2021 4:17 PM]	32.07	0.37 (1.17%)	31.70	0.0 (0.00%)	21.78 - 56.18	460,390	480,000	5,202
Revolution Medicines EPS misses by $0.10, misses on revenue [11/10/2021 4:17 PM] Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress [Nov-10-21 04:05PM] Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Lags Revenue Estimates [Nov-10-21 05:55PM]
11-08-2021	AH	4:05 PM ET (Aug 11)	RVMD	Revolution Medicines, Inc.	2,010	-0.60	-0.55	-0.46	Revolution Medicines EPS misses by $0.05, misses on revenue [8/11/2021 4:15 PM]	23.95	-2.95 (-10.97%)	23.70	-3.20 (-11.90%)	21.78 - 56.18	3,239,567	500,000	3,361
Revolution Medicines EPS misses by $0.05, misses on revenue [8/11/2021 4:15 PM] Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress [Aug-11-21 04:01PM] Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Misses Revenue Estimates [Aug-11-21 05:25PM]
10-05-2021	AH	4:05 PM ET (May 10)	RVMD	Revolution Medicines, Inc.	2,130	-0.53	-0.52	0.00	Revolution Medicines EPS misses by $0.01, beats on revenue [5/10/2021 4:40 PM]	31.68	1.88 (6.31%)	29.80	0.0 (0.00%)	21.17 - 56.18	520,138	1,120,000	8,527
Revolution Medicines EPS misses by $0.01, beats on revenue [5/10/2021 4:40 PM] Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress [May-10-21 04:05PM] Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates [May-10-21 06:15PM]